Search Results - Sutcharitchan, P.

Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C by Cappellini, M.D., Elalfy, M., El-Beshlawy, A., Kattamis, A., Chan, L.L., Li, C., Lin, K.H., Quarta, G., Sutcharitchan, P., Taher, A., Habr, D., Roubert, B., Porter, J.

Get full text

Insights into relationships between serum ferritin and liver iron concentration trends during 12 months of iron chelation therapy with deferasirox - a post-hoc analysis from the ep... by Porter, J.B., Elalfy, M., Taher, A.T., Chan, L.L., Lee, S.H., Sutcharitchan, P., Aydinok, Y., Chakravarty, S., El-Ali, A., El-Beshlawy, A.

Get full text

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia by Pennell, D.J., Porter, J.B., Cappellini, M.D., El-Beshlawy, A., Chan, L.L., Aydinok, Y., Elalfy, M.S., Sutcharitchan, P., Li, C.K., Ibrahim, H., Viprakasit, V., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.

Get full text